Active Shortage

LACOSAMIDE INJECTION, USP

HIKMA CANADA LIMITED

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of LACOSAMIDE INJECTION, USP in Canada?

Yes. LACOSAMIDE INJECTION, USP 10MG has an active shortage reported to Health Canada (last updated November 26, 2024).

Why is LACOSAMIDE INJECTION, USP not available?

The reason the manufacturer reported: Requirements related to complying with good manufacturing practices.

When will LACOSAMIDE INJECTION, USP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file6 products · 0 same form & route

Affected strength10MG

Report last updated2024-11-26

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

SANDOZ LACOSAMIDE

SANDOZ CANADA INCORPORATED

50MG · DIN 02474670

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

VIMPAT

UCB CANADA INC

100MG · DIN 02357623

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

TEVA-LACOSAMIDE

TEVA CANADA LIMITED

100MG · DIN 02472910

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

ZDS-LACOSAMIDE

ZYDUS PHARMACEUTICALS (CANADA) INC

50MG · DIN 02487802

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

PHARMA-LACOSAMIDE

PHARMASCIENCE INC

100MG · DIN 02478218

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

JAMP-LACOSAMIDE

JAMP PHARMA CORPORATION

200MG · DIN 02488426

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02541343

Strength

10MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

LACOSAMIDE

Tier

Unrated

Last Updated

2024-11-26

Reason for Shortage

Requirements related to complying with good manufacturing practices.

Source

View original report on healthproductshortages.ca ↗

Other Products from HIKMA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02304341

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02459906

ATROPINE INJECTION BP

0.6MG · DIN 02432196

ATROPINE INJECTION BP

0.4MG · DIN 02432188

AZACITIDINE FOR INJECTION

100MG · DIN 02507668

BACLOFEN INJECTION

0.05MG · DIN 02457059

BACLOFEN INJECTION

2MG · DIN 02457075

BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION

0.2% · DIN 02515377

CEFAZOLIN FOR INJECTION

500MG · DIN 02437104

CEFAZOLIN FOR INJECTION

1G · DIN 02437112

CEFAZOLIN FOR INJECTION

10G · DIN 02437120

CEFEPIME FOR INJECTION USP

2G · DIN 02499096